Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
Douglas C ChungMaryam GhaediKathrin WarnerAzin SayadSamuel D SaibilMarcus Q BernardiniBlaise A ClarkePatricia A ShawMarcus O ButlerAlexandra EassonA Sorana MorrissyBen X WangLinh NguyenPamela S OhashiJacquelot NPublished in: Oncoimmunology (2024)
The innate lymphoid cell (ILC) family is composed of heterogeneous innate effector and helper immune cells that preferentially reside in tissues where they promote tissue homeostasis. In cancer, they have been implicated in driving both pro- and anti-tumor responses. This apparent dichotomy highlights the need to better understand differences in the ILC composition and phenotype within different tumor types that could drive seemingly opposite anti-tumor responses. Here, we characterized the frequency and phenotype of various ILC subsets in melanoma metastases and primary epithelial ovarian tumors. We observed high PD-1 expression on ILC subsets isolated from epithelial ovarian tumor samples, while ILC populations in melanoma samples express higher levels of LAG-3. In addition, we found that the frequency of cytotoxic ILCs and NKp46 + ILC3 in tumors positively correlates with monocytic cells and conventional type 2 dendritic cells, revealing potentially new interconnected immune cell subsets in the tumor microenvironment. Consequently, these observations may have direct relevance to tumor microenvironment composition and how ILC subset may influence anti-tumor immunity.
Keyphrases
- nk cells
- dendritic cells
- peripheral blood
- immune response
- regulatory t cells
- induced apoptosis
- cell therapy
- gene expression
- poor prognosis
- magnetic resonance imaging
- papillary thyroid
- computed tomography
- young adults
- squamous cell carcinoma
- binding protein
- bone marrow
- cell cycle arrest
- basal cell carcinoma
- type iii
- childhood cancer